Cercar
01/01/2025
VALIDATION OF THE "CANNABIS WITHDRAWAL SYMPTOM SCALE" IN THE SPANISH POPULATION
Saura, J, Enríquez, M, Fu, M, Ballbè, M, Roca, X, Andreu, M, Barrio, P, Fernández, E, Martínez, C. VALIDATION OF THE "CANNABIS WITHDRAWAL SYMPTOM SCALE" IN THE SPANISH POPULATION. Gaceta Sanitaria. 2025; 39DOI:. PMID:. IF:1.500(Q3/7D).
07/03/2025
No significant differences in postoperative clinical outcomes evolution after fresh osteochondral allograft transplantation of the knee between patients with pathological and non-pathological scores regarding anxiety, depression, kinesiophobia and catastrophizing factors
Gelber, PE, Ramírez-Bermejo, E, Castellà-Pujol, A, Gonzalez-Osuna, A, Fariñas, O. No significant differences in postoperative clinical outcomes evolution after fresh osteochondral allograft transplantation of the knee between patients with pathological and non-pathological scores regarding anxiety, depression, kinesiophobia and catastrophizing factors. Journal Of Experimental Orthopaedics. 2025; 12(1)DOI:10.1002/jeo2.70210. PMID:40059956. IF:(Q/D).
01/01/2025
A narrative review of vascular conduits for coronary artery bypass grafting
Iraola-Picornell, G, Berastegui, E, Castells-Sala, C, Martorell, J, Bayes-Genis, A, Muñoz-Guijosa, C, Gálvez-Monton, C. A narrative review of vascular conduits for coronary artery bypass grafting. CELL TRANSPLANTATION. 2025; 34DOI:10.1177/09636897251407160. PMID:41437519. IF:3.200(Q1/1D).
28/09/2021
Transplantation of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium in a Swine Model of Geographic Atrophy.
Duarri A, Rodríguez-Bocanegra E, Martínez-Navarrete G, Biarnés M, García M, Ferraro LL, Kuebler B, Aran B, Izquierdo E, Aguilera-Xiol E, Casaroli-Marano RP, Trias E, Fernandez E, Raya Á, Veiga A, Monés J. Transplantation of Human Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium in a Swine Model of Geographic Atrophy.. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021; 22(19)DOI:10.3390/ijms221910497. PMID:34638840. IF:6.208(Q1/3D).
15/10/2021
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia
Avendano-Sola, C, Ramos-Martinez, A, Munez-Rubio, E, Ruiz-Antoran, B, de Molina, RM, Torres, F, Fernandez-Cruz, A, Calderon-Parra, J, Payares-Herrera, C, de Santiago, AD, Romera-Martinez, I, Pintos, I, Lora-Tamayo, J, Mancheno-Losa, M, Paciello, ML, Martinez-Gonzalez, AL, Vidan-Estevez, J, Nunez-Orantos, MJ, Saez-Serrano, MI, Porras-Leal, ML, Jarilla-Fernandez, MC, Villares, P, de Oteyza, JP, Ramos-Garrido, A, Blanco, L, Madrigal-Sanchez, ME, Rubio-Batlles, M, Velasco-Iglesias, A, Pano-Pardo, JR, Moreno-Chulilla, JA, Muniz-Diaz, E, Casas-Flecha, I, Perez-Olmeda, M, Garcia-Perez, J, Alcami, J, Bueno, JL, Duarte, RF, Bösch A., Villegas da Ros, Carolina. A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia. JOURNAL OF CLINICAL INVESTIGATION. 2021; 131(20)DOI:10.1172/JCI152740. PMID:34473652. IF:19.477(Q1/1D).
01/08/2021
Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis
Demelo-Rodriguez, P, Farfan-Sedano, AI, Pedrajas, JM, Llamas, P, Siguenza, P, Jaras, MJ, Quintana-Diaz, M, Fernandez-Capitan, C, Bikdeli, B, Jimenez, D, Monreal, M, Olivera P.E., RIETE-BLEEDING Investigators. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis. JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2021; 19(8)DOI:10.1111/jth.15400. PMID:34018658. IF:16.041(Q1/1D).